These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 19616325)
1. Overreaction to noncompaction in a patient with ankylosing spondylitis, Parkinson disease, migraine and myopathy. Stöllberger C; Stix A; Finsterer J Int J Cardiol; 2011 Jul; 150(1):e11-4. PubMed ID: 19616325 [TBL] [Abstract][Full Text] [Related]
2. Ventricular and supraventricular arrhythmias and heart failure in a patient with left ventricular noncompaction and Brugada syndrome. Kaźmierczak J; Zielonka J; Peregud-Pogorzelska M; Kiedrowicz R; Wielusiński M Cardiol J; 2011; 18(3):310-3. PubMed ID: 21660923 [TBL] [Abstract][Full Text] [Related]
3. Failure of transvenous ICD to terminate ventricular fibrillation in a patient with left ventricular noncompaction and polycystic kidneys. Pastore G; Zanon F; Baracca E; Piva M; Bernardi A; Piergentili C; Rigatelli G; Roncon L; Barold SS Pacing Clin Electrophysiol; 2012 Feb; 35(2):e40-2. PubMed ID: 20946291 [TBL] [Abstract][Full Text] [Related]
4. Myopathy, left ventricular noncompaction, and tetralogy of fallot. Stöllberger C; Steger C; Finsterer J Clin Cardiol; 2009 Nov; 32(11):E46-8. PubMed ID: 19816976 [TBL] [Abstract][Full Text] [Related]
9. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium. Sakai Y; Sato Y; Matsuo S; Imai S; Kunimasa T; Matsumoto N; Saito S Int J Cardiol; 2007 May; 117(3):e104-6. PubMed ID: 17350119 [TBL] [Abstract][Full Text] [Related]
10. Dilated cardiomyopathy associated with Bechterew disease and myopathy. Finsterer J; Stöllberger C; Schweinzer C South Med J; 2009 Dec; 102(12):1277-8. PubMed ID: 20016443 [No Abstract] [Full Text] [Related]
11. Noncompacted ventricular myocardium: is syncope the only warning sign? Ho TQ; Lenihan DJ; Kantharia BK; Dougherty AH Am J Med Sci; 2010 May; 339(5):497-500. PubMed ID: 20386101 [TBL] [Abstract][Full Text] [Related]
12. Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy. Caliskan K; Szili-Torok T; Theuns DA; Kardos A; Geleijnse ML; Balk AH; van Domburg RT; Jordaens L; Simoons ML J Cardiovasc Electrophysiol; 2011 Aug; 22(8):898-904. PubMed ID: 21332865 [TBL] [Abstract][Full Text] [Related]
13. [Acute cerebral ischemia: an unusual clinical presentation of isolated left ventricular noncompaction in an adult patient]. Fiorencis A; Quadretti L; Bacich D; Chiodi E; Mele D; Fiorencis R G Ital Cardiol (Rome); 2013 Jan; 14(1):79-82. PubMed ID: 23258208 [TBL] [Abstract][Full Text] [Related]
14. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB; Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702 [TBL] [Abstract][Full Text] [Related]
15. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction. Finsterer J; Stöllberger C; Fazio G Curr Pharm Des; 2010; 16(26):2895-904. PubMed ID: 20632953 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of left ventricular hypertrabeculation/noncompaction among children with sickle cell disease. Morrison ML; McMahon C; Tully R; Enright N; Pignatelli R; Towbin JA; McMahon CJ Congenit Heart Dis; 2018 May; 13(3):440-443. PubMed ID: 29468808 [TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrabeculation/noncompaction associated with coronary heart disease and myopathy. Finsterer J; Stöllberger C; Bonner E Int J Cardiol; 2011 May; 148(3):e53-5. PubMed ID: 19342113 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]